Free Trial

Palvella Therapeutics (PVLA) Institutional Ownership

Palvella Therapeutics logo
$52.71 -1.44 (-2.66%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Palvella Therapeutics (NASDAQ:PVLA)

Current
Institutional Ownership
Percentage
40.11%
Number of
Institutional Buyers
(last 12 months)
31
Total
Institutional Inflows
(last 12 months)
$74.01M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$3.71M
Get PVLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Palvella Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PVLA Institutional Buying and Selling by Quarter

Palvella Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Frazier Life Sciences Management L.P.722,400$16.28M0.7%+4.7%6.532%
8/15/2025 BNP Paribas Financial Markets4,630$104K0.0%N/A0.042%
8/15/2025 Bank of America Corp DE4,174$94K0.0%-45.1%0.038%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,750$85K0.0%N/A0.034%
8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 43,994$992K0.1%-9.6%0.398%
8/13/2025 Marshall Wace LLP49,077$1.11M0.0%+61.7%0.444%
8/13/2025 New York State Common Retirement Fund4,900$110K0.0%N/A0.044%
8/13/2025 Adams Street Partners LLC298,986$6.74M4.7%-27.0%2.703%
8/12/2025 XTX Topco Ltd17,701$399K0.0%N/A0.160%
8/12/2025 Rhumbline Advisers9,956$224K0.0%N/A0.090%
8/12/2025 JPMorgan Chase & Co.3,245$73K0.0%+108,066.7%0.029%
8/8/2025 Police & Firemen s Retirement System of New Jersey1,639$37K0.0%N/A0.015%
8/8/2025 Geode Capital Management LLC173,986$3.92M0.0%+84.7%1.574%
7/22/2025 Strid Group LLC18,166$409K0.1%-37.8%0.164%
7/14/2025 Clio Asset Management LLC91,508$2.06M1.6%N/A0.828%
6/27/2025 Goldman Sachs Group Inc.19,053$533K0.0%N/A0.172%
5/16/2025 Woodline Partners LP194,167$5.44M0.0%N/A1.758%
5/16/2025 Goldman Sachs Group Inc.19,053$533K0.0%N/A0.173%
5/16/2025 Millennium Management LLC269,837$7.55M0.0%N/A2.444%
5/16/2025 AWM Investment Company Inc.69,416$1.94M0.3%N/A0.629%
5/15/2025 Frazier Life Sciences Management L.P.690,012$19.31M0.9%+5.5%6.248%
5/15/2025 DAFNA Capital Management LLC43,348$1.21M0.3%-39.3%0.393%
5/6/2025 Royce & Associates LP71,514$2.00M0.0%N/A0.648%
4/25/2025 Strid Group LLC29,219$818K0.1%N/A0.265%
4/23/2025 Spire Wealth Management2,516$70K0.0%N/A0.023%
2/19/2025 Toronto Dominion Bank13,211$159K0.0%N/A0.118%
2/18/2025 Frazier Life Sciences Management L.P.653,892$7.85M0.3%N/A5.828%
2/17/2025 Toronto Dominion Bank13,211$159K0.0%N/A0.118%
2/17/2025 Suvretta Capital Management LLC714,463$8.57M0.3%N/A6.367%
2/17/2025 DAFNA Capital Management LLC71,452$857K0.2%N/A0.637%
2/17/2025 Cresset Asset Management LLC20,911$251K0.0%N/A0.186%
2/17/2025 Citadel Advisors LLC10,408$125K0.0%N/A0.093%
2/17/2025 BVF Inc. IL696,555$8.36M0.3%N/A6.208%
2/17/2025 Adams Street Partners LLC409,666$4.92M4.4%N/A3.651%
2/14/2025 Samsara BioCapital LLC679,486$8.15M1.1%N/A6.056%
2/14/2025 Nantahala Capital Management LLC250,062$3.00M0.1%N/A2.229%
2/14/2025 Blue Owl Capital Holdings LP250,062$3.00M0.7%N/A2.229%
2/13/2025 Renaissance Technologies LLC21,371$256K0.0%N/A0.190%
2/13/2025 ADAR1 Capital Management LLC144,641$1.74M0.3%N/A1.289%
2/12/2025 Geode Capital Management LLC14,270$171K0.0%N/A0.127%
2013 Bitcoin miner reveals his trading system (free) (Ad)

While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematically extracting profits from the $4 billion that changes hands in crypto every single day.tc pixel

2/7/2025 BML Capital Management LLC42,130$506K0.3%N/A0.375%
(Data available from 1/1/2016 forward)

PVLA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PVLA shares?

During the previous two years, 33 institutional investors and hedge funds held shares of Palvella Therapeutics. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($16.28M), Suvretta Capital Management LLC ($8.57M), BVF Inc. IL ($8.36M), Samsara BioCapital LLC ($8.15M), Millennium Management LLC ($7.55M), Adams Street Partners LLC ($6.74M), and Woodline Partners LP ($5.44M).Learn more on Palvella Therapeutics' institutional investors.

What percentage of Palvella Therapeutics' stock is owned by institutional investors?

40.11% of Palvella Therapeutics' stock is owned by institutional investors. Learn more on PVLA's institutional investor holdings.

Which institutional investors have been buying Palvella Therapeutics' stock?

Of the 31 institutional investors that purchased Palvella Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($722.40K), Suvretta Capital Management LLC ($714.46K), BVF Inc. IL ($696.56K), Samsara BioCapital LLC ($679.49K), Adams Street Partners LLC ($409.67K), Millennium Management LLC ($269.84K), and Blue Owl Capital Holdings LP ($250.06K).

How much institutional buying is happening at Palvella Therapeutics?

Institutional investors have bought a total of 4,984,919 shares in the last 24 months. This purchase volume represents approximately $74.01M in transactions.

Which of Palvella Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Palvella Therapeutics stock in the last 24 months: Adams Street Partners LLC ($110.68K), DAFNA Capital Management LLC ($28.10K), Strid Group LLC ($11.05K), OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($4.67K), and Bank of America Corp DE ($3.44K).

How much institutional selling is happening at Palvella Therapeutics?

Institutional investors have sold a total of 157,942 shares in the last 24 months. This volume of shares sold represents approximately $3.71M in transactions.



This page (NASDAQ:PVLA) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners